Announcement

Collapse
No announcement yet.

Respirol Case Rep . Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Respirol Case Rep . Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis

    Respirol Case Rep


    . 2024 Sep 12;12(9):e01446.
    doi: 10.1002/rcr2.1446. eCollection 2024 Sep. Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis

    Khaled Musameh 1 , Shane O'Brien 1 , Roshane Mehboob 1 , Thomas Butler 1 , Zara Cunningham 1 , Carol Buckley 1 , Armin Atzinger 2 , Torsten Kuwert 2 , Patrick Mitchell 1 , Seamas C Donnelly 1



    AffiliationsAbstract

    Coronavirus disease 2019 (COVID-19) often leads to a spectrum of pulmonary complications, including interstitial lung disease (ILD) with the potential for fibrotic sequelae. Assessing the presence of ongoing active inflammation versus established residual fibrosis as a result of lung parenchymal injury and repair in these patients is a clinical challenge. Better understanding of the disease process is crucial for guiding appropriate therapeutic strategies. We aim to investigate the use of positron emission tomography / computer tomography (PET/CT) scans and their role in diagnosing interstitial pneumonitis (IP) post COVID infections.

    Keywords: coronavirus disease 2019; interstitial lung disease; progressive Fibrosing interstitial lung disease.

Working...
X